A Case of Complex Movement Disorder Induced by Fluoxetine With Management of Dystonia by Botulinum Toxin Type A

J. Chen and David M. Swope

MY ACCOUNT

X All Individual Users: You may have noticed, we have just launched our new website. We will be adding more features over the upcoming weeks that you will like, so there may be a few hiccups along the way. If this is your first time visiting since our relaunch, please reset your password so you can still access our journals and CME activities that we have been providing for over 80 years. If you have any questions or comments please contact us at webadmin@psychiatrist.com.

Movement Disorder
A Case of Complex Movement...

A Case of Complex Movement Disorder Induced by Fluoxetine With Management of Dystonia by Botulinum Toxin Type A

J. Chen, PharmD, BCPS, CGP, and David M. Swope, MD

J Clin Psychiatry 2005;66(2):267-268

A Case of Complex Movement Disorder Induced by Fluoxetine With Management of Dystonia by Botulinum Toxin Type A

Serum Fatty Acid Latent Classes Are Associated With Suicide in a Large Military Personnel Sample

Levels of several fatty acids (FAs) have been linked to suicidal behavior, though research...

Cross-Cutting Symptom Domains Predict Functioning in Psychotic Disorders

Read this study to learn how both psychotic and nonpsychotic symptom domains predict funct...

Single Versus Multiple Daily Dosing Regimens of Psychotropic Drugs for Psychiatric Disorders: A Systematic Review and Meta-Analysis

Single-daily-dose regimens are easier for patients to follow than multiple-dose regimens a...

A Case of Complex Movement Disorder Induced by Fluoxetine With Management of Dystonia by Botulinum Toxin Type A

Sign-up to stay up-to-date today!

Already registered? Sign In

Sign-up to stay
up-to-date today!